One-Liner
A system for pushing protocol amendments to 5% of trial sites first, measuring error rates and IRB turnaround, before full rollout — transplanting software canary-deployment logic into clinical trial operations.
AI Thinking Process
Clinical Operations Lead managing 80-200 sites across 15 countries faces 3.5 protocol amendments per trial (Tufts CSDD 2020). Simultaneous push to all sites causes IRB delays at 30% of sites and patient-enrollment errors. Cost of bad amendment: $1-5M rework.
Verb Transplant: software canary deployment (push change to 5% traffic, measure error rate, auto-rollback) → protocol amendment canary: push new protocol to 5% of sites, measure IRB turnaround + enrollment error + AE rate delta for 4 weeks before full rollout.
Veeva Vault CTMS, Medidata Rave, Oracle Siebel CTMS — handle amendments as 'distribute and hope.' Clinical-ink, Vial, Faro Health — protocol design tools not canary rollout. No canary-rollout-for-trials competitor recalled.
structural adoption barrier: sponsors want protocols to work first time. A canary implicitly admits amendments may be wrong — statisticians fear protocol heterogeneity on primary endpoint analysis.
FUNDAMENTAL BARRIER: FDA guidance requires all sites to operate under the same protocol version at a given time. Rolling canary = half sites on old protocol = data-cleanliness failure. Not positional.
Pivot to 'dry-run readiness canary' — pilot IRB submission mechanics with 5% of sites, no actual enrollment. No protocol heterogeneity, catches 80% of operational failures.
Dry-run pivot = 'amendment pre-flight checklist' = feature of existing CTMS. Medidata roadmap Q3 2026 mentions amendment change-impact analysis. Fundamental kill stands; pivot absorbed by incumbents.
Resurrection check: FDA guidance prohibits protocol heterogeneity — FUNDAMENTAL barrier not positional. Readiness-canary pivot is CTMS feature absorbed by Medidata. Resurrection FAILED.
Kill Reason
FDA guidance requires all trial sites to operate under the same protocol version at any given time; rolling canary creates half the sites on old protocol and half on new, which is a data-cleanliness problem for the primary endpoint analysis. This is a fundamental regulatory prohibition, not a positional barrier. The 'readiness canary' pivot (dry-run IRB + site mechanics without actual enrollment) collapsed into a CTMS amendment pre-flight feature that Medidata's Q3 2026 roadmap already covers.
Risk Analysis
Risk analysis available for latest engine ideas.
What do you think?
Related ideas you can explore free:
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.
killed: Template epidemic (G003) + industry-pain-form death pattern (G005) fire simultaneously. 13+ existing compliance tools. A prompt could do 80% of this.